Posted by Michael Wonder on 16 Nov 2019
PBAC Public Summary Documents - July 2019 meeting
15 November 2019 - The Public Summary Documents (first time rejections and deferrals) from the July 2019 PBAC meeting are now available.
The Public Summary Documents reveal the PBAC's has a different acceptable threshold for different diseases/situations. For some medicines, the PBAC has stated that it is prepared to make a recommendation if the base-case ICER (cost/QALY gained) is <$30,000, for others the ICER needs to be <$40,000 and in another, <$70,000.
